Logo image of SN

SHARKNINJA INC (SN) Stock Fundamental Analysis

NYSE:SN - New York Stock Exchange, Inc. - KYG8068L1086 - Common Stock - Currency: USD

110.99  -0.2 (-0.18%)

After market: 110.99 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SN. SN was compared to 63 industry peers in the Household Durables industry. SN has an excellent profitability rating, but there are some minor concerns on its financial health. SN is valued quite expensively, but it does show have an excellent growth rating. These ratings would make SN suitable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year SN was profitable.
In the past year SN had a positive cash flow from operations.
Each year in the past 5 years SN has been profitable.
In the past 5 years SN always reported a positive cash flow from operatings.
SN Yearly Net Income VS EBIT VS OCF VS FCFSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

SN's Return On Assets of 10.70% is amongst the best of the industry. SN outperforms 84.13% of its industry peers.
Looking at the Return On Equity, with a value of 21.93%, SN belongs to the top of the industry, outperforming 87.30% of the companies in the same industry.
SN has a better Return On Invested Capital (14.32%) than 80.95% of its industry peers.
SN had an Average Return On Invested Capital over the past 3 years of 11.61%. This is in line with the industry average of 10.55%.
The last Return On Invested Capital (14.32%) for SN is above the 3 year average (11.61%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.7%
ROE 21.93%
ROIC 14.32%
ROA(3y)7.28%
ROA(5y)N/A
ROE(3y)15.56%
ROE(5y)N/A
ROIC(3y)11.61%
ROIC(5y)N/A
SN Yearly ROA, ROE, ROICSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

SN's Profit Margin of 7.86% is fine compared to the rest of the industry. SN outperforms 63.49% of its industry peers.
SN's Profit Margin has declined in the last couple of years.
SN has a better Operating Margin (11.17%) than 68.25% of its industry peers.
In the last couple of years the Operating Margin of SN has remained more or less at the same level.
SN's Gross Margin of 48.17% is amongst the best of the industry. SN outperforms 90.48% of its industry peers.
In the last couple of years the Gross Margin of SN has grown nicely.
Industry RankSector Rank
OM 11.17%
PM (TTM) 7.86%
GM 48.17%
OM growth 3Y-0.31%
OM growth 5YN/A
PM growth 3Y-3.69%
PM growth 5YN/A
GM growth 3Y7.66%
GM growth 5YN/A
SN Yearly Profit, Operating, Gross MarginsSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

SN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SN has been increased compared to 1 year ago.
SN has a better debt/assets ratio than last year.
SN Yearly Shares OutstandingSN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M
SN Yearly Total Debt VS Total AssetsSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

SN has an Altman-Z score of 6.95. This indicates that SN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.95, SN belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
SN has a debt to FCF ratio of 4.10. This is a neutral value as SN would need 4.10 years to pay back of all of its debts.
The Debt to FCF ratio of SN (4.10) is better than 61.90% of its industry peers.
A Debt/Equity ratio of 0.36 indicates that SN is not too dependend on debt financing.
SN has a Debt to Equity ratio (0.36) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 4.1
Altman-Z 6.95
ROIC/WACC1.62
WACC8.82%
SN Yearly LT Debt VS Equity VS FCFSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

SN has a Current Ratio of 1.97. This is a normal value and indicates that SN is financially healthy and should not expect problems in meeting its short term obligations.
SN has a worse Current ratio (1.97) than 63.49% of its industry peers.
A Quick Ratio of 1.17 indicates that SN should not have too much problems paying its short term obligations.
SN has a Quick ratio of 1.17. This is in the better half of the industry: SN outperforms 63.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.17
SN Yearly Current Assets VS Current LiabilitesSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

7

3. Growth

3.1 Past

SN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 133.72%, which is quite impressive.
The Earnings Per Share has been growing by 9.32% on average over the past years. This is quite good.
SN shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.33%.
SN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)133.72%
EPS 3Y9.32%
EPS 5YN/A
EPS Q2Q%-17.92%
Revenue 1Y (TTM)27.33%
Revenue growth 3Y14.05%
Revenue growth 5YN/A
Sales Q2Q%14.67%

3.2 Future

SN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.59% yearly.
Based on estimates for the next years, SN will show a quite strong growth in Revenue. The Revenue will grow by 9.92% on average per year.
EPS Next Y17.95%
EPS Next 2Y16.21%
EPS Next 3Y15.5%
EPS Next 5Y17.59%
Revenue Next Year16.49%
Revenue Next 2Y14%
Revenue Next 3Y12.55%
Revenue Next 5Y9.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SN Yearly Revenue VS EstimatesSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SN Yearly EPS VS EstimatesSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.49 indicates a quite expensive valuation of SN.
Based on the Price/Earnings ratio, SN is valued a bit more expensive than the industry average as 63.49% of the companies are valued more cheaply.
SN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.47.
SN is valuated rather expensively with a Price/Forward Earnings ratio of 18.76.
Based on the Price/Forward Earnings ratio, SN is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
SN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.49
Fwd PE 18.76
SN Price Earnings VS Forward Price EarningsSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SN is valued a bit more expensive than the industry average as 68.25% of the companies are valued more cheaply.
SN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 83.81
EV/EBITDA 21.28
SN Per share dataSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

SN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SN has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SN's earnings are expected to grow with 15.50% in the coming years.
PEG (NY)1.48
PEG (5Y)N/A
EPS Next 2Y16.21%
EPS Next 3Y15.5%

0

5. Dividend

5.1 Amount

SN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SHARKNINJA INC

NYSE:SN (7/11/2025, 4:32:22 PM)

After market: 110.99 0 (0%)

110.99

-0.2 (-0.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners50.32%
Inst Owner Change0%
Ins Owners2.52%
Ins Owner Change0%
Market Cap15.65B
Analysts85.71
Price Target126.54 (14.01%)
Short Float %6.49%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.76%
Min EPS beat(2)6.52%
Max EPS beat(2)15.01%
EPS beat(4)4
Avg EPS beat(4)9.03%
Min EPS beat(4)3.19%
Max EPS beat(4)15.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.17%
Min Revenue beat(2)1.63%
Max Revenue beat(2)6.7%
Revenue beat(4)4
Avg Revenue beat(4)6.08%
Min Revenue beat(4)1.63%
Max Revenue beat(4)11.39%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.22%
PT rev (3m)-7.01%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)-24.15%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.79%
Revenue NQ rev (1m)-0.35%
Revenue NQ rev (3m)-6.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 26.49
Fwd PE 18.76
P/S 2.75
P/FCF 83.81
P/OCF 45
P/B 7.68
P/tB 21.04
EV/EBITDA 21.28
EPS(TTM)4.19
EY3.78%
EPS(NY)5.91
Fwd EY5.33%
FCF(TTM)1.32
FCFY1.19%
OCF(TTM)2.47
OCFY2.22%
SpS40.31
BVpS14.45
TBVpS5.27
PEG (NY)1.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.7%
ROE 21.93%
ROCE 21.44%
ROIC 14.32%
ROICexc 15.5%
ROICexgc 29.41%
OM 11.17%
PM (TTM) 7.86%
GM 48.17%
FCFM 3.29%
ROA(3y)7.28%
ROA(5y)N/A
ROE(3y)15.56%
ROE(5y)N/A
ROIC(3y)11.61%
ROIC(5y)N/A
ROICexc(3y)12.86%
ROICexc(5y)N/A
ROICexgc(3y)30.15%
ROICexgc(5y)N/A
ROCE(3y)17.37%
ROCE(5y)N/A
ROICexcg growth 3Y-1.34%
ROICexcg growth 5YN/A
ROICexc growth 3Y7.9%
ROICexc growth 5YN/A
OM growth 3Y-0.31%
OM growth 5YN/A
PM growth 3Y-3.69%
PM growth 5YN/A
GM growth 3Y7.66%
GM growth 5YN/A
F-Score7
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 4.1
Debt/EBITDA 0.95
Cap/Depr 126.62%
Cap/Sales 2.83%
Interest Coverage 250
Cash Conversion 45.64%
Profit Quality 41.79%
Current Ratio 1.97
Quick Ratio 1.17
Altman-Z 6.95
F-Score7
WACC8.82%
ROIC/WACC1.62
Cap/Depr(3y)119.55%
Cap/Depr(5y)102.74%
Cap/Sales(3y)2.79%
Cap/Sales(5y)2.44%
Profit Quality(3y)68%
Profit Quality(5y)65.21%
High Growth Momentum
Growth
EPS 1Y (TTM)133.72%
EPS 3Y9.32%
EPS 5YN/A
EPS Q2Q%-17.92%
EPS Next Y17.95%
EPS Next 2Y16.21%
EPS Next 3Y15.5%
EPS Next 5Y17.59%
Revenue 1Y (TTM)27.33%
Revenue growth 3Y14.05%
Revenue growth 5YN/A
Sales Q2Q%14.67%
Revenue Next Year16.49%
Revenue Next 2Y14%
Revenue Next 3Y12.55%
Revenue Next 5Y9.92%
EBIT growth 1Y56.46%
EBIT growth 3Y13.7%
EBIT growth 5YN/A
EBIT Next Year31.76%
EBIT Next 3Y17.19%
EBIT Next 5YN/A
FCF growth 1Y-34.99%
FCF growth 3Y20.46%
FCF growth 5YN/A
OCF growth 1Y-12.13%
OCF growth 3Y24.92%
OCF growth 5YN/A